Aptevo Therapeutics - Hyperimmune Commercial Products was acquired by Saol Therapeutics on August 31, 2017

Medical ProductsCompany

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2017. The largest medical products acquisition in 2017 was C. R. Bard - which was acquired by Becton Dickinson for $24.0B.

Join Mergr to view all 209 acquisitions of medical products companies in 2017, including 27 acquisitions by private equity firms, and 182 by strategics.

Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products

Seattle, Washington 98101
United States,

Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products comprises WinRho SDF, HepaGam B, and VARIZIG. WinRho SDF for autoimmune platelet disorder and hemolytic disease of the newborn; HepaGam B for the prevention of Hepatitis B following liver transplantation and for treatment following hepatitis B exposure; and VARIZIG for treatment following exposure to varicella zoster virus for individuals with compromised immune systems.


 Subscribe to unlock this and 189,272
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 180K M&A Transactions
  • 185K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 68K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.